We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Conceptus, Inc. (MM) | NASDAQ:CPTS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 31.02 | 0 | 01:00:00 |
From May 2019 to May 2024
FRANKFURT--Bayer AG (BAYN.XE) said Wednesday its takeover bid for Conceptus Inc. (CPTS) has been successful and it plans to merge the U.S. pharmaceutical company with a Bayer subsidiary.
The total value of the transaction amounts to about $1.1 billion (EUR852 million), said the German drug and pesticide maker. Slightly more than 96% of outstanding Conceptus shares were tendered and not withdrawn in the offer as of its expiration.
Write to Friedrich Geiger at friedrich.geiger@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Conceptus, Inc. (MM) Chart |
1 Month Conceptus, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
